Avid Bioservices Inc (CDMO)

[Globewriter]

Confidential Treatment Order sealed thru July 16, 2021

https://ir.avidbio.com/static-files/b0a5c734-582a-4aaa-a0cd-c6185d92bbeb

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION August 21, 2018
ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934
Avid Bioservices, Inc.
File No. 1-32839 - CF#36507 _____________________
Avid Bioservices, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibit to a Form 10-K filed on July 16, 2018.
Based on representations by Avid Bioservices, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit will not be released to the public for the time period specified:

Exhibit 10.11 through July 16, 2021

For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Brent J. Fields Secretary